5147 related articles for article (PubMed ID: 3798833)
1. [Indications for prophylactic lymphadenectomy in skin melanoma of the lower limbs].
Vagner RI; Anisimov VV
Vopr Onkol; 1986; 32(12):13-8. PubMed ID: 3798833
[TBL] [Abstract][Full Text] [Related]
2. [Indications for preventive regional lymphadenectomy in primary melanoma of the skin of the trunk].
Vagner RI; Anisimov VV
Vestn Khir Im I I Grek; 1986 Nov; 137(11):40-3. PubMed ID: 3824782
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
4. [Indications for preventive regional lymphadenectomy in primary melanoma of the skin of the head and neck].
Vagner RI; Anisimov VV; Zhuravlev KV
Vestn Khir Im I I Grek; 1988 Oct; 141(10):8-12. PubMed ID: 3242243
[TBL] [Abstract][Full Text] [Related]
5. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
6. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
7. [Indications for regional lymphadenectomy in melanoblastoma of the skin of the extremities].
Vagner RI; Khachaturian LM
Vopr Onkol; 1974; 20(9):33-8. PubMed ID: 4428655
[No Abstract] [Full Text] [Related]
8. [Prophylactic lymph node excision in cutaneous melanomas of the lower limbs].
Zhuravlev KV; Barchuk AS; Vagner RI; Anisimov VV
Vopr Onkol; 1994; 40(1-3):59-64. PubMed ID: 7701795
[TBL] [Abstract][Full Text] [Related]
9. [Indications for preventive axillary lymphadenectomy in melanoma of the skin of the upper extremity].
Vagner RI; Anisimov VV
Vestn Khir Im I I Grek; 1987 May; 138(5):46-50. PubMed ID: 3672737
[TBL] [Abstract][Full Text] [Related]
10. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
14. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
15. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities].
Kjaer BK; Knudsen MA; Dahlstrøm KK
Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040
[TBL] [Abstract][Full Text] [Related]
16. Management of malignant melanoma.
Kroon BB; Nieweg OE
Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
[TBL] [Abstract][Full Text] [Related]
17. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
19. Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity.
Pu LL; Cruse CW; Wells KE; Shons AR; Reintgen DS
Ann Plast Surg; 2003 Jul; 51(1):69-76. PubMed ID: 12838128
[TBL] [Abstract][Full Text] [Related]
20. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
